|
Symbol Name ID |
Clptm1l
CLPTM1-like MGI:2442892 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Clptm1lem1(IMPC)J/Clptm1lem1(IMPC)J C57BL/6NJ-Clptm1lem1(IMPC)J/Mmjax |
cataract | J:211773 |
| decreased bone mineral content | J:211773 | |
| decreased circulating alkaline phosphatase level | J:211773 | |
| decreased exploration in new environment | J:211773 | |
| decreased grip strength | J:211773 | |
| decreased locomotor activity | J:211773 | |
| hyperactivity | J:211773 | |
| increased prepulse inhibition | J:211773 | |
| increased vertical activity | J:211773 | |
| Clptm1ltm1d(EUCOMM)Wtsi/Clptm1l+ involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N |
abnormal class switch recombination | J:265892 |
| Clptm1ltm1d(EUCOMM)Wtsi/Clptm1ltm1d(EUCOMM)Wtsi involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N |
decreased survivor rate | J:265892 |
| normal immune system phenotype | J:265892 | |
| neonatal lethality, incomplete penetrance | J:265892 | |
| prenatal lethality, incomplete penetrance | J:265892 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||